Greenwich LifeSciences, Inc.

TickerCurrent Price% Daily ChangeVolume (1,000s)Average Volumn (1,000s)Market Cap (Millions)1/2/2024 Price% Change Since Inception 1/2/2024
GLSI$14.83-4.507%6046$191$10.8037.3%

Contact Information

Greenwich LifeSciences, Inc.
Building 14
3992 Bluebonnet Drive
Stafford, TX 77477
United States

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and has commenced a Phase III clinical trial, called Flamingo-01.